Potassium Chloride 10 MEQ Extended Release Oral Capsule

1 INDICATIONS AND USAGE Potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium Chloride Extended-release Capsules, USP contain potassium chloride, a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.

paddock laboratories, llc

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] dyspnoea` `[5] diarrhoea` `[6] pain` `[7] headache` `[8] off label use` `[9] dizziness` `[10] vomiting`

4 years ago

CAPSULE WHITE PAD 0181

4 years ago

PAD 0181 CAPSULE WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Potassium chloride extended-release capsules contain 600 mg and 750 mg mg of potassium chloride (equivalent to 8 mEq and 10 mEq, respectively). Table 1: How Supplied Dose Color Printing Bottle Count NDC 600 mg (8 mEq) white PAD over 0180 100 0574-0180-01 750 mg (10 mEq) white PAD over 0181 90 0574-0181-90 100 0574-0181-01 500 0574-0181-05 Store at 20°-25°C (68°-77°F) [ see USP Controlled Room Temperature ]. Dispense in tight container. Rx only

More pills like CAPSULE PAD 0181

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Potassium Chloride 10 MEQ Extended Release Oral Capsule

FDA Reported Adverse Reactions [1] fatigue [2] nausea [3] drug ineffective [4] dyspnoea [5] diarrhoea [6] pain [7] headache [8] off label use [9] dizziness [10] vomiting

CAPSULE WHITE PAD 0181

PAD 0181 CAPSULE WHITE

More pills like CAPSULE PAD 0181

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] dyspnoea` `[5] diarrhoea` `[6] pain` `[7] headache` `[8] off label use` `[9] dizziness` `[10] vomiting`